Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital.
C-reactive protein
Elderly
Pneumonia
Pneumonia severity
Procalcitonin
Prognosis
Journal
BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548
Informations de publication
Date de publication:
07 01 2019
07 01 2019
Historique:
received:
28
09
2018
accepted:
10
12
2018
entrez:
9
1
2019
pubmed:
9
1
2019
medline:
19
11
2019
Statut:
epublish
Résumé
Procalcitonin (PCT) is a useful marker for pneumonia. However, its clinical usefulness in elderly patients has not been studied extensively. This study aimed to assess the relationship between PCT and prognosis and pneumonia severity in elderly patients with pneumonia acquired outside the hospital. Data considered relevant to pneumonia severity and prognosis were retrospectively obtained from clinical charts of all patients with pneumonia who were admitted to our hospital from 2010 to 2017. The primary outcome was 30-day mortality in elderly patients (aged ≥75 years), and the relationship between PCT levels and pneumonia severity, as determined by the pneumonia severity index (PSI) was also examined. Data were collected from 667 patients, of which 436 were elderly patients. Multivariate and receiver operating characteristic curve analysis revealed that albumin, body mass index, and PSI class rather than PCT are important factors related to 30-day mortality in elderly patients. PCT was also not an independent prognostic factor in younger patients. PCT levels significantly differed by pneumonia severity (mild, moderate, and severe) in both younger (p < 0.001) and elderly (p < 0.0001) patients, with levels increasing as severity increased. In contrast, C-reactive protein (CRP) levels and white blood cell counts did not significantly differ by pneumonia severity in younger and elderly patients. A subgroup analysis focused on Streptococcus pneumoniae pneumonia revealed that PCT levels differed by severity in elderly patients (p = 0.03), with levels increasing as severity increased. PCT was not an independent predictor of 30-day mortality in both of elderly and younger patients. PCT levels, but not CRP levels, significantly increased with increasing pneumonia severity in younger and elderly patients, although the degree of increase tended to be lower in elderly patients compared to younger patients for the same severity. PCT levels also significantly increased with increasing pneumonia severity in elderly patients with Streptococcus pneumoniae pneumonia.
Sections du résumé
BACKGROUND
Procalcitonin (PCT) is a useful marker for pneumonia. However, its clinical usefulness in elderly patients has not been studied extensively. This study aimed to assess the relationship between PCT and prognosis and pneumonia severity in elderly patients with pneumonia acquired outside the hospital.
METHODS
Data considered relevant to pneumonia severity and prognosis were retrospectively obtained from clinical charts of all patients with pneumonia who were admitted to our hospital from 2010 to 2017. The primary outcome was 30-day mortality in elderly patients (aged ≥75 years), and the relationship between PCT levels and pneumonia severity, as determined by the pneumonia severity index (PSI) was also examined.
RESULTS
Data were collected from 667 patients, of which 436 were elderly patients. Multivariate and receiver operating characteristic curve analysis revealed that albumin, body mass index, and PSI class rather than PCT are important factors related to 30-day mortality in elderly patients. PCT was also not an independent prognostic factor in younger patients. PCT levels significantly differed by pneumonia severity (mild, moderate, and severe) in both younger (p < 0.001) and elderly (p < 0.0001) patients, with levels increasing as severity increased. In contrast, C-reactive protein (CRP) levels and white blood cell counts did not significantly differ by pneumonia severity in younger and elderly patients. A subgroup analysis focused on Streptococcus pneumoniae pneumonia revealed that PCT levels differed by severity in elderly patients (p = 0.03), with levels increasing as severity increased.
CONCLUSION
PCT was not an independent predictor of 30-day mortality in both of elderly and younger patients. PCT levels, but not CRP levels, significantly increased with increasing pneumonia severity in younger and elderly patients, although the degree of increase tended to be lower in elderly patients compared to younger patients for the same severity. PCT levels also significantly increased with increasing pneumonia severity in elderly patients with Streptococcus pneumoniae pneumonia.
Identifiants
pubmed: 30616612
doi: 10.1186/s12877-018-1008-8
pii: 10.1186/s12877-018-1008-8
pmc: PMC6323702
doi:
Substances chimiques
Biomarkers
0
Procalcitonin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3Références
Lancet Infect Dis. 2018 Jan;18(1):95-107
pubmed: 29037960
Eur J Clin Microbiol Infect Dis. 2012 May;31(5):825-33
pubmed: 21870054
N Engl J Med. 1997 Jan 23;336(4):243-50
pubmed: 8995086
Ann Emerg Med. 2008 Jul;52(1):48-58.e2
pubmed: 18342993
Nat Immunol. 2013 May;14(5):428-36
pubmed: 23598398
J Crit Care. 2011 Jun;26(3):287-94
pubmed: 21129911
Scand J Clin Lab Invest. 2017 Nov;77(7):486-492
pubmed: 28678546
Scand J Infect Dis. 2014 Nov;46(11):787-91
pubmed: 25195651
Tuberc Respir Dis (Seoul). 2013 May;74(5):207-14
pubmed: 23750168
J Intern Med. 2008 Aug;264(2):166-76
pubmed: 18298480
BMC Pulm Med. 2017 May 2;17(1):78
pubmed: 28464807
Eur Respir J. 2011 Feb;37(2):384-92
pubmed: 20595156
J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1:S4-9
pubmed: 24833586
J Am Geriatr Soc. 2005 Aug;53(8):1392-5
pubmed: 16078967
Ann Thorac Med. 2015 Apr-Jun;10(2):137-42
pubmed: 25829966
BMC Geriatr. 2017 Aug 1;17(1):173
pubmed: 28764651
Respir Care. 2014 Aug;59(8):1258-66
pubmed: 24327749
Chest. 2005 Oct;128(4):2223-9
pubmed: 16236878
Enferm Infecc Microbiol Clin. 2015 Oct;33(8):521-4
pubmed: 25541006
Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72
pubmed: 17278083
Am J Emerg Med. 2012 Sep;30(7):1248-54
pubmed: 22030193
Am J Respir Crit Care Med. 2005 Feb 15;171(4):388-416
pubmed: 15699079
J Infect. 2013 May;66(5):415-23
pubmed: 23286966
Thorax. 2010 Oct;65(10):878-83
pubmed: 20729231
Obes Rev. 2009 May;10(3):280-9
pubmed: 19243518
Thorax. 2009 Jul;64(7):587-91
pubmed: 19131448
Clin Infect Dis. 2013 Mar;56(5):625-32
pubmed: 23155150
Eur Respir J. 2012 Nov;40(5):1201-10
pubmed: 22408203
J Infect. 2010 Jun;60(6):409-16
pubmed: 20347867
Thorax. 2010 Oct;65(10):884-90
pubmed: 20729235
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Clin Lab. 2014;60(1):139-42
pubmed: 24600988
J Infect Chemother. 2018 Aug;24(8):602-609
pubmed: 29628384
Open Forum Infect Dis. 2017 Jan 04;4(1):ofw238
pubmed: 28480236
BMC Geriatr. 2016 Jan 15;16:16
pubmed: 26772604
Am J Respir Crit Care Med. 2005 Jan 1;171(1):48-53
pubmed: 15447947
J Bras Pneumol. 2011 Jul-Aug;37(4):495-503
pubmed: 21881740
Respir Care. 2014 Apr;59(4):574-81
pubmed: 24106319
J Infect. 2012 Jan;64(1):122-4
pubmed: 22079501
Respirology. 2008 Jun;13(4):505-9
pubmed: 18422867
Ann Thorac Med. 2014 Jul;9(3):162-7
pubmed: 24987476
Infection. 2005 Aug;33(4):257-63
pubmed: 16091896
Public Health Rep. 1989 Jul-Aug;104(4):350-60
pubmed: 2502806
Eur Respir J. 2008 Feb;31(2):349-55
pubmed: 17959641
Arch Intern Med. 2002 May 13;162(9):1059-64
pubmed: 11996618
Respir Care. 2014 Apr;59(4):564-73
pubmed: 24170911
Anesthesiology. 2002 Jan;96(1):74-9
pubmed: 11753005
Chest. 2012 Apr;141(4):974-982
pubmed: 22135381
Eur J Clin Microbiol Infect Dis. 2009 Jan;28(1):55-60
pubmed: 18677519
Arch Gerontol Geriatr. 2019 Jan - Feb;80:53-57
pubmed: 30366226
Cell Physiol Biochem. 2015;37(5):1967-72
pubmed: 26584295
Respiration. 2016;92(4):241-251
pubmed: 27623169